Immune senescence in multiple myeloma—a role for mitochondrial dysfunction? View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2022-07-25

AUTHORS

Frances Seymour, Jonathan Carmichael, Claire Taylor, Christopher Parrish, Gordon Cook

ABSTRACT

Age-related immune dysfunction is primarily mediated by immunosenescence which results in ineffective clearance of infective pathogens, poor vaccine responses and increased susceptibility to multi-morbidities. Immunosenescence-related immunometabolic abnormalities are associated with accelerated aging, an inflammatory immune response (inflammaging) and ultimately frailty syndromes. In addition, several conditions can accelerate the development of immunosenescence, including cancer. This is a bi-directional interaction since inflammaging may create a permissive environment for tumour development. Multiple myeloma (MM) is a mature B-cell malignancy that presents in the older population. MM exemplifies the interaction of age- (Host Response Biology; HRB) and disease-related immunological dysfunction, contributing to the development of a frailty syndrome which impairs the therapeutic impact of recent advances in treatment strategies. Understanding the mechanisms by which accelerated immunological aging is induced and the ways in which a tumour such as MM influences this process is key to overcoming therapeutic barriers. A link between cellular mitochondrial dysfunction and the acquisition of an abnormal immune phenotype has recently been described and has widespread physiological consequence beyond the impact on the immune system. Here we outline our current understanding of normal immune aging, describe the mechanism of immunometabolic dysfunction in accelerating this process, and propose the role these processes are playing in the pathogenesis of MM. More... »

PAGES

1-6

References to SciGraph publications

  • 2020-08-20. Association of TIM-3 expression with glucose metabolism in Jurkat T cells in BMC IMMUNOLOGY
  • 2018-12-20. Trajectories of inflammatory biomarkers over the eighth decade and their associations with immune cell profiles and epigenetic ageing in CLINICAL EPIGENETICS
  • 2018-07-31. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty in NATURE REVIEWS CARDIOLOGY
  • 2013-09-13. Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance in BLOOD CANCER JOURNAL
  • 2019-10-14. The relative importance of factors predicting outcome for myeloma patients at different ages: results from 3894 patients in the Myeloma XI trial in LEUKEMIA
  • 2020-06-18. Defining the vulnerable patient with myeloma—a frailty position paper of the European Myeloma Network in LEUKEMIA
  • 2021-03-17. The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis in NATURE
  • 2015-10-16. Alterations in bone marrow metabolism are an early and consistent feature during the development of MGUS and multiple myeloma in BLOOD CANCER JOURNAL
  • 2005-09-12. MUC1 oncoprotein is targeted to mitochondria by heregulin-induced activation of c-Src and the molecular chaperone HSP90 in ONCOGENE
  • 2012-03-14. The inverted CD4/CD8 ratio and associated parameters in 66-year-old individuals: the Swedish HEXA immune study in GEROSCIENCE
  • 2019-07-08. Mitochondrial DNA: the overlooked oncogenome? in BMC BIOLOGY
  • 2014-11-04. Osteoarthritis and telomere shortening in JOURNAL OF APPLIED GENETICS
  • 2020-08-14. Micro-environmental sensing by bone marrow stroma identifies IL-6 and TGFβ1 as regulators of hematopoietic ageing in NATURE COMMUNICATIONS
  • 2016-07-11. A guide to immunometabolism for immunologists in NATURE REVIEWS IMMUNOLOGY
  • 2016-04-22. Multiple myeloma causes clonal T-cell immunosenescence: identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade in LEUKEMIA
  • 2018-07-25. Inflammaging: a new immune–metabolic viewpoint for age-related diseases in NATURE REVIEWS ENDOCRINOLOGY
  • 2009-06-10. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment in NATURE
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/s41375-022-01653-7

    DOI

    http://dx.doi.org/10.1038/s41375-022-01653-7

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1149722226

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/35879358


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Immunology", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Haematology, Leeds Cancer Centre, Leeds Teaching Hospitals Trust, Leeds, UK", 
              "id": "http://www.grid.ac/institutes/grid.415967.8", 
              "name": [
                "Department of Haematology, Leeds Cancer Centre, Leeds Teaching Hospitals Trust, Leeds, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Seymour", 
            "givenName": "Frances", 
            "id": "sg:person.015172240742.43", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015172240742.43"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "NIHR (Leeds) Medtech & In vitro Diagnostic Cooperative, Leeds, UK", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Department of Haematology, Leeds Cancer Centre, Leeds Teaching Hospitals Trust, Leeds, UK", 
                "NIHR (Leeds) Medtech & In vitro Diagnostic Cooperative, Leeds, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Carmichael", 
            "givenName": "Jonathan", 
            "id": "sg:person.011027575153.03", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011027575153.03"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Experimental Haematology, Leeds Institute of Medical Research, University of Leeds UK, Leeds, UK", 
              "id": "http://www.grid.ac/institutes/grid.9909.9", 
              "name": [
                "Experimental Haematology, Leeds Institute of Medical Research, University of Leeds UK, Leeds, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Taylor", 
            "givenName": "Claire", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trial Research, University of Leeds UK, Leeds, UK", 
              "id": "http://www.grid.ac/institutes/grid.470294.c", 
              "name": [
                "Department of Haematology, Leeds Cancer Centre, Leeds Teaching Hospitals Trust, Leeds, UK", 
                "Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trial Research, University of Leeds UK, Leeds, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Parrish", 
            "givenName": "Christopher", 
            "id": "sg:person.0634367132.56", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634367132.56"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trial Research, University of Leeds UK, Leeds, UK", 
              "id": "http://www.grid.ac/institutes/grid.470294.c", 
              "name": [
                "Department of Haematology, Leeds Cancer Centre, Leeds Teaching Hospitals Trust, Leeds, UK", 
                "NIHR (Leeds) Medtech & In vitro Diagnostic Cooperative, Leeds, UK", 
                "Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trial Research, University of Leeds UK, Leeds, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Cook", 
            "givenName": "Gordon", 
            "id": "sg:person.07624006200.62", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07624006200.62"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/s41467-020-17942-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1130099969", 
              "https://doi.org/10.1038/s41467-020-17942-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41375-019-0595-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1121785543", 
              "https://doi.org/10.1038/s41375-019-0595-5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature08099", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1011517403", 
              "https://doi.org/10.1038/nature08099"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41569-018-0064-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1105908367", 
              "https://doi.org/10.1038/s41569-018-0064-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s13148-018-0585-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1110810776", 
              "https://doi.org/10.1186/s13148-018-0585-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41586-021-03341-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1136442535", 
              "https://doi.org/10.1038/s41586-021-03341-5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11357-012-9400-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035418247", 
              "https://doi.org/10.1007/s11357-012-9400-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41574-018-0059-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1105808736", 
              "https://doi.org/10.1038/s41574-018-0059-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s12865-020-00377-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1130234056", 
              "https://doi.org/10.1186/s12865-020-00377-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1209012", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033209687", 
              "https://doi.org/10.1038/sj.onc.1209012"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/leu.2016.84", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019926798", 
              "https://doi.org/10.1038/leu.2016.84"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/bcj.2013.34", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014893564", 
              "https://doi.org/10.1038/bcj.2013.34"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/bcj.2015.85", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1007925228", 
              "https://doi.org/10.1038/bcj.2015.85"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nri.2016.70", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003163126", 
              "https://doi.org/10.1038/nri.2016.70"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41375-020-0918-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1128560392", 
              "https://doi.org/10.1038/s41375-020-0918-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s13353-014-0251-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1027513085", 
              "https://doi.org/10.1007/s13353-014-0251-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/s12915-019-0668-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1117842930", 
              "https://doi.org/10.1186/s12915-019-0668-y"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2022-07-25", 
        "datePublishedReg": "2022-07-25", 
        "description": "Age-related immune dysfunction is primarily mediated by immunosenescence which results in ineffective clearance of infective pathogens, poor vaccine responses and increased susceptibility to multi-morbidities. Immunosenescence-related immunometabolic abnormalities are associated with accelerated aging, an inflammatory immune response (inflammaging) and ultimately frailty syndromes. In addition, several conditions can accelerate the development of immunosenescence, including cancer. This is a bi-directional interaction since inflammaging may create a permissive environment for tumour development. Multiple myeloma (MM) is a mature B-cell malignancy that presents in the older population. MM exemplifies the interaction of age- (Host Response Biology; HRB) and disease-related immunological dysfunction, contributing to the development of a frailty syndrome which impairs the therapeutic impact of recent advances in treatment strategies. Understanding the mechanisms by which accelerated immunological aging is induced and the ways in which a tumour such as MM influences this process is key to overcoming therapeutic barriers. A link between cellular mitochondrial dysfunction and the acquisition of an abnormal immune phenotype has recently been described and has widespread physiological consequence beyond the impact on the immune system. Here we outline our current understanding of normal immune aging, describe the mechanism of immunometabolic dysfunction in accelerating this process, and propose the role these processes are playing in the pathogenesis of MM.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/s41375-022-01653-7", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1097065", 
            "issn": [
              "0887-6924", 
              "1476-5551"
            ], 
            "name": "Leukemia", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }
        ], 
        "keywords": [
          "multiple myeloma", 
          "frailty syndrome", 
          "age-related immune dysfunction", 
          "pathogenesis of MM", 
          "poor vaccine responses", 
          "development of immunosenescence", 
          "abnormal immune phenotype", 
          "mitochondrial dysfunction", 
          "inflammatory immune response", 
          "B-cell malignancies", 
          "mature B-cell malignancies", 
          "ineffective clearance", 
          "immunological aging", 
          "immunometabolic dysfunction", 
          "immune dysfunction", 
          "vaccine responses", 
          "immune senescence", 
          "immunological dysfunction", 
          "immune aging", 
          "immune phenotype", 
          "therapeutic barriers", 
          "cellular mitochondrial dysfunction", 
          "treatment strategies", 
          "immune response", 
          "therapeutic impact", 
          "interaction of age", 
          "dysfunction", 
          "infective pathogens", 
          "immune system", 
          "older population", 
          "tumor development", 
          "immunosenescence", 
          "myeloma", 
          "syndrome", 
          "permissive environment", 
          "bi-directional interaction", 
          "physiological consequences", 
          "widespread physiological consequences", 
          "current understanding", 
          "malignancy", 
          "pathogenesis", 
          "tumors", 
          "cancer", 
          "abnormalities", 
          "clearance", 
          "response", 
          "age", 
          "aging", 
          "recent advances", 
          "role", 
          "phenotype", 
          "pathogens", 
          "population", 
          "susceptibility", 
          "mechanism", 
          "development", 
          "senescence", 
          "impact", 
          "barriers", 
          "advances", 
          "addition", 
          "consequences", 
          "strategies", 
          "Accelerated", 
          "interaction", 
          "understanding", 
          "acquisition", 
          "link", 
          "conditions", 
          "process", 
          "influence", 
          "system", 
          "way", 
          "environment"
        ], 
        "name": "Immune senescence in multiple myeloma\u2014a role for mitochondrial dysfunction?", 
        "pagination": "1-6", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1149722226"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/s41375-022-01653-7"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "35879358"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/s41375-022-01653-7", 
          "https://app.dimensions.ai/details/publication/pub.1149722226"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-09-02T16:07", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_938.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/s41375-022-01653-7"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41375-022-01653-7'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41375-022-01653-7'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41375-022-01653-7'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41375-022-01653-7'


     

    This table displays all metadata directly associated to this object as RDF triples.

    236 TRIPLES      21 PREDICATES      114 URIs      89 LITERALS      5 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/s41375-022-01653-7 schema:about anzsrc-for:11
    2 anzsrc-for:1107
    3 schema:author Nb70ec795831946839a00738b404f0305
    4 schema:citation sg:pub.10.1007/s11357-012-9400-3
    5 sg:pub.10.1007/s13353-014-0251-8
    6 sg:pub.10.1038/bcj.2013.34
    7 sg:pub.10.1038/bcj.2015.85
    8 sg:pub.10.1038/leu.2016.84
    9 sg:pub.10.1038/nature08099
    10 sg:pub.10.1038/nri.2016.70
    11 sg:pub.10.1038/s41375-019-0595-5
    12 sg:pub.10.1038/s41375-020-0918-6
    13 sg:pub.10.1038/s41467-020-17942-7
    14 sg:pub.10.1038/s41569-018-0064-2
    15 sg:pub.10.1038/s41574-018-0059-4
    16 sg:pub.10.1038/s41586-021-03341-5
    17 sg:pub.10.1038/sj.onc.1209012
    18 sg:pub.10.1186/s12865-020-00377-6
    19 sg:pub.10.1186/s12915-019-0668-y
    20 sg:pub.10.1186/s13148-018-0585-x
    21 schema:datePublished 2022-07-25
    22 schema:datePublishedReg 2022-07-25
    23 schema:description Age-related immune dysfunction is primarily mediated by immunosenescence which results in ineffective clearance of infective pathogens, poor vaccine responses and increased susceptibility to multi-morbidities. Immunosenescence-related immunometabolic abnormalities are associated with accelerated aging, an inflammatory immune response (inflammaging) and ultimately frailty syndromes. In addition, several conditions can accelerate the development of immunosenescence, including cancer. This is a bi-directional interaction since inflammaging may create a permissive environment for tumour development. Multiple myeloma (MM) is a mature B-cell malignancy that presents in the older population. MM exemplifies the interaction of age- (Host Response Biology; HRB) and disease-related immunological dysfunction, contributing to the development of a frailty syndrome which impairs the therapeutic impact of recent advances in treatment strategies. Understanding the mechanisms by which accelerated immunological aging is induced and the ways in which a tumour such as MM influences this process is key to overcoming therapeutic barriers. A link between cellular mitochondrial dysfunction and the acquisition of an abnormal immune phenotype has recently been described and has widespread physiological consequence beyond the impact on the immune system. Here we outline our current understanding of normal immune aging, describe the mechanism of immunometabolic dysfunction in accelerating this process, and propose the role these processes are playing in the pathogenesis of MM.
    24 schema:genre article
    25 schema:isAccessibleForFree false
    26 schema:isPartOf sg:journal.1097065
    27 schema:keywords Accelerated
    28 B-cell malignancies
    29 abnormal immune phenotype
    30 abnormalities
    31 acquisition
    32 addition
    33 advances
    34 age
    35 age-related immune dysfunction
    36 aging
    37 barriers
    38 bi-directional interaction
    39 cancer
    40 cellular mitochondrial dysfunction
    41 clearance
    42 conditions
    43 consequences
    44 current understanding
    45 development
    46 development of immunosenescence
    47 dysfunction
    48 environment
    49 frailty syndrome
    50 immune aging
    51 immune dysfunction
    52 immune phenotype
    53 immune response
    54 immune senescence
    55 immune system
    56 immunological aging
    57 immunological dysfunction
    58 immunometabolic dysfunction
    59 immunosenescence
    60 impact
    61 ineffective clearance
    62 infective pathogens
    63 inflammatory immune response
    64 influence
    65 interaction
    66 interaction of age
    67 link
    68 malignancy
    69 mature B-cell malignancies
    70 mechanism
    71 mitochondrial dysfunction
    72 multiple myeloma
    73 myeloma
    74 older population
    75 pathogenesis
    76 pathogenesis of MM
    77 pathogens
    78 permissive environment
    79 phenotype
    80 physiological consequences
    81 poor vaccine responses
    82 population
    83 process
    84 recent advances
    85 response
    86 role
    87 senescence
    88 strategies
    89 susceptibility
    90 syndrome
    91 system
    92 therapeutic barriers
    93 therapeutic impact
    94 treatment strategies
    95 tumor development
    96 tumors
    97 understanding
    98 vaccine responses
    99 way
    100 widespread physiological consequences
    101 schema:name Immune senescence in multiple myeloma—a role for mitochondrial dysfunction?
    102 schema:pagination 1-6
    103 schema:productId N1ba62b8a407d4ebf940a896a60324ce0
    104 N34d106dbebea4aee83eb5fe78521df61
    105 N5d5e62cce4504b30839f7e6685fe7e56
    106 schema:sameAs https://app.dimensions.ai/details/publication/pub.1149722226
    107 https://doi.org/10.1038/s41375-022-01653-7
    108 schema:sdDatePublished 2022-09-02T16:07
    109 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    110 schema:sdPublisher N56b6579fdbf943abae8ae5c7594be05f
    111 schema:url https://doi.org/10.1038/s41375-022-01653-7
    112 sgo:license sg:explorer/license/
    113 sgo:sdDataset articles
    114 rdf:type schema:ScholarlyArticle
    115 N1ba62b8a407d4ebf940a896a60324ce0 schema:name dimensions_id
    116 schema:value pub.1149722226
    117 rdf:type schema:PropertyValue
    118 N34d106dbebea4aee83eb5fe78521df61 schema:name pubmed_id
    119 schema:value 35879358
    120 rdf:type schema:PropertyValue
    121 N56b6579fdbf943abae8ae5c7594be05f schema:name Springer Nature - SN SciGraph project
    122 rdf:type schema:Organization
    123 N5d5e62cce4504b30839f7e6685fe7e56 schema:name doi
    124 schema:value 10.1038/s41375-022-01653-7
    125 rdf:type schema:PropertyValue
    126 N80a809cdc1174652afac6b9bbaf31b4e schema:affiliation grid-institutes:grid.9909.9
    127 schema:familyName Taylor
    128 schema:givenName Claire
    129 rdf:type schema:Person
    130 Naeefec1641104dabb9bd36ce306b476e rdf:first sg:person.07624006200.62
    131 rdf:rest rdf:nil
    132 Nb70ec795831946839a00738b404f0305 rdf:first sg:person.015172240742.43
    133 rdf:rest Nfa4ec0b0b2f5443196eb40144cfed220
    134 Nbfe17cd704cc4c9cb202baf5f42cf98d rdf:first sg:person.0634367132.56
    135 rdf:rest Naeefec1641104dabb9bd36ce306b476e
    136 Nf172bd22ef56421caaaca470d7caffc8 rdf:first N80a809cdc1174652afac6b9bbaf31b4e
    137 rdf:rest Nbfe17cd704cc4c9cb202baf5f42cf98d
    138 Nfa4ec0b0b2f5443196eb40144cfed220 rdf:first sg:person.011027575153.03
    139 rdf:rest Nf172bd22ef56421caaaca470d7caffc8
    140 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    141 schema:name Medical and Health Sciences
    142 rdf:type schema:DefinedTerm
    143 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
    144 schema:name Immunology
    145 rdf:type schema:DefinedTerm
    146 sg:journal.1097065 schema:issn 0887-6924
    147 1476-5551
    148 schema:name Leukemia
    149 schema:publisher Springer Nature
    150 rdf:type schema:Periodical
    151 sg:person.011027575153.03 schema:affiliation grid-institutes:None
    152 schema:familyName Carmichael
    153 schema:givenName Jonathan
    154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011027575153.03
    155 rdf:type schema:Person
    156 sg:person.015172240742.43 schema:affiliation grid-institutes:grid.415967.8
    157 schema:familyName Seymour
    158 schema:givenName Frances
    159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015172240742.43
    160 rdf:type schema:Person
    161 sg:person.0634367132.56 schema:affiliation grid-institutes:grid.470294.c
    162 schema:familyName Parrish
    163 schema:givenName Christopher
    164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634367132.56
    165 rdf:type schema:Person
    166 sg:person.07624006200.62 schema:affiliation grid-institutes:grid.470294.c
    167 schema:familyName Cook
    168 schema:givenName Gordon
    169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07624006200.62
    170 rdf:type schema:Person
    171 sg:pub.10.1007/s11357-012-9400-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035418247
    172 https://doi.org/10.1007/s11357-012-9400-3
    173 rdf:type schema:CreativeWork
    174 sg:pub.10.1007/s13353-014-0251-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027513085
    175 https://doi.org/10.1007/s13353-014-0251-8
    176 rdf:type schema:CreativeWork
    177 sg:pub.10.1038/bcj.2013.34 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014893564
    178 https://doi.org/10.1038/bcj.2013.34
    179 rdf:type schema:CreativeWork
    180 sg:pub.10.1038/bcj.2015.85 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007925228
    181 https://doi.org/10.1038/bcj.2015.85
    182 rdf:type schema:CreativeWork
    183 sg:pub.10.1038/leu.2016.84 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019926798
    184 https://doi.org/10.1038/leu.2016.84
    185 rdf:type schema:CreativeWork
    186 sg:pub.10.1038/nature08099 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011517403
    187 https://doi.org/10.1038/nature08099
    188 rdf:type schema:CreativeWork
    189 sg:pub.10.1038/nri.2016.70 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003163126
    190 https://doi.org/10.1038/nri.2016.70
    191 rdf:type schema:CreativeWork
    192 sg:pub.10.1038/s41375-019-0595-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1121785543
    193 https://doi.org/10.1038/s41375-019-0595-5
    194 rdf:type schema:CreativeWork
    195 sg:pub.10.1038/s41375-020-0918-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1128560392
    196 https://doi.org/10.1038/s41375-020-0918-6
    197 rdf:type schema:CreativeWork
    198 sg:pub.10.1038/s41467-020-17942-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1130099969
    199 https://doi.org/10.1038/s41467-020-17942-7
    200 rdf:type schema:CreativeWork
    201 sg:pub.10.1038/s41569-018-0064-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105908367
    202 https://doi.org/10.1038/s41569-018-0064-2
    203 rdf:type schema:CreativeWork
    204 sg:pub.10.1038/s41574-018-0059-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105808736
    205 https://doi.org/10.1038/s41574-018-0059-4
    206 rdf:type schema:CreativeWork
    207 sg:pub.10.1038/s41586-021-03341-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1136442535
    208 https://doi.org/10.1038/s41586-021-03341-5
    209 rdf:type schema:CreativeWork
    210 sg:pub.10.1038/sj.onc.1209012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033209687
    211 https://doi.org/10.1038/sj.onc.1209012
    212 rdf:type schema:CreativeWork
    213 sg:pub.10.1186/s12865-020-00377-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1130234056
    214 https://doi.org/10.1186/s12865-020-00377-6
    215 rdf:type schema:CreativeWork
    216 sg:pub.10.1186/s12915-019-0668-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1117842930
    217 https://doi.org/10.1186/s12915-019-0668-y
    218 rdf:type schema:CreativeWork
    219 sg:pub.10.1186/s13148-018-0585-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1110810776
    220 https://doi.org/10.1186/s13148-018-0585-x
    221 rdf:type schema:CreativeWork
    222 grid-institutes:None schema:alternateName NIHR (Leeds) Medtech & In vitro Diagnostic Cooperative, Leeds, UK
    223 schema:name Department of Haematology, Leeds Cancer Centre, Leeds Teaching Hospitals Trust, Leeds, UK
    224 NIHR (Leeds) Medtech & In vitro Diagnostic Cooperative, Leeds, UK
    225 rdf:type schema:Organization
    226 grid-institutes:grid.415967.8 schema:alternateName Department of Haematology, Leeds Cancer Centre, Leeds Teaching Hospitals Trust, Leeds, UK
    227 schema:name Department of Haematology, Leeds Cancer Centre, Leeds Teaching Hospitals Trust, Leeds, UK
    228 rdf:type schema:Organization
    229 grid-institutes:grid.470294.c schema:alternateName Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trial Research, University of Leeds UK, Leeds, UK
    230 schema:name Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trial Research, University of Leeds UK, Leeds, UK
    231 Department of Haematology, Leeds Cancer Centre, Leeds Teaching Hospitals Trust, Leeds, UK
    232 NIHR (Leeds) Medtech & In vitro Diagnostic Cooperative, Leeds, UK
    233 rdf:type schema:Organization
    234 grid-institutes:grid.9909.9 schema:alternateName Experimental Haematology, Leeds Institute of Medical Research, University of Leeds UK, Leeds, UK
    235 schema:name Experimental Haematology, Leeds Institute of Medical Research, University of Leeds UK, Leeds, UK
    236 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...